Ledger.Open graph →

SEC Form D · filed April 9, 2015

Edge Therapeutics, Inc

Offering

$56.0M

Sold

$56.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

BERKELEY HEIGHTS, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Robert L. Macdonald · Berkeley Heights, NJExec · Director Kurt J. Conti · Berkeley Heights, NJDirector Herbert J. Faleck · Berkeley Heights, NJExec Carl J. Soranno · Berkeley Heights, NJExec Andrew L. Einhorn · Berkeley Heights, NJExec Albert N. Marchio Ii · Berkeley Heights, NJExec Sol J. Barer · Berkeley Heights, NJDirector Brian A. Leuthner · Berkeley Heights, NJExec · Director James J. Loughlin · Berkeley Heights, NJDirector Isaac J. Blech · Berkeley Heights, NJDirector Robert J. Spiegel · Berkeley Heights, NJDirector Neil W. Brown · Roseville, MNExec · Director Sanaz Cordes · Madison, WIExec Richard M. Specht · Allen, TXExec · Director Bradley G. Huckle · Roseville, MNExec · Director Michael M. Casey · San Mateo, CAExec · Director Michael A. Bilski · Roseville, MNExec · Director Lyle Berkowitz · Madison, WIExec · Director Todd Spartz · San Mateo, CADirector Anders Engdahl · Kalispell, MTExec Charles Pearce · Kalispell, MTDirector James Strainer · Kalispell, MTExec · Director Amy Mckerrow · Kalispell, MTDirector D. B. Baker · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗